273 related articles for article (PubMed ID: 33431200)
1. Diagnostic pathway of the biopsy-naïve patient suspected for prostate cancer: Real-life scenario when multiparametric Magnetic Resonance Imaging is not centralized.
Bertolo R; Vittori M; Cipriani C; Maiorino F; Forte V; Iacovelli V; Petta F; Sperandio M; Marani C; Panei M; Travaglia S; Bove P
Prog Urol; 2021 Oct; 31(12):739-746. PubMed ID: 33431200
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Pathway with Multiparametric Magnetic Resonance Imaging Versus Standard Pathway: Results from a Randomized Prospective Study in Biopsy-naïve Patients with Suspected Prostate Cancer.
Porpiglia F; Manfredi M; Mele F; Cossu M; Bollito E; Veltri A; Cirillo S; Regge D; Faletti R; Passera R; Fiori C; De Luca S
Eur Urol; 2017 Aug; 72(2):282-288. PubMed ID: 27574821
[TBL] [Abstract][Full Text] [Related]
3. The predictive value of the prostate health index vs. multiparametric magnetic resonance imaging for prostate cancer diagnosis in prostate biopsy.
Stejskal J; Adamcová V; Záleský M; Novák V; Čapoun O; Fiala V; Dolejšová O; Sedláčková H; Veselý Š; Zachoval R
World J Urol; 2021 Jun; 39(6):1889-1895. PubMed ID: 32761380
[TBL] [Abstract][Full Text] [Related]
4. Can multiparametric magnetic resonance of the prostate avoid biopsies in patients with elevated PSA and surgical indication for benign prostatic enlargement?
Wroclawski ML; Kayano PP; Amaral BS; Mariotti GC; Yamauchi FI; Cha JD; Carneiro A; Korkes F; Vitalli AS; Mussi TC; Lemos GC; Baroni RH
Abdom Radiol (NY); 2020 Oct; 45(10):3278-3282. PubMed ID: 31974659
[TBL] [Abstract][Full Text] [Related]
5. Detection of Gleason 6 prostate cancer in patients with clinically significant prostate cancer on multiparametric magnetic resonance imaging.
Chaloupka M; Bischoff R; Pfitzinger P; Lellig E; Ledderose S; Buchner A; Schlenker B; Stief C; Clevert DA; Apfelbeck M
Clin Hemorheol Microcirc; 2019; 73(1):105-111. PubMed ID: 31561351
[TBL] [Abstract][Full Text] [Related]
6. Do cancer detection rates differ between transperineal and transrectal micro-ultrasound mpMRI-fusion-targeted prostate biopsies? A propensity score-matched study.
Rakauskas A; Peters M; Martel P; van Rossum PSN; La Rosa S; Meuwly JY; Roth B; Valerio M
PLoS One; 2023; 18(1):e0280262. PubMed ID: 36652429
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomized controlled trial comparing target prostate biopsy alone approach vs. target plus standard in naïve patients with positive mpMRI.
Porpiglia F; Checcucci E; DE Cillis S; Piramide F; Amparore D; Piana A; Volpi G; Granato S; Zamengo D; Stura I; Alladio E; Migliaretti G; DE Luca S; Bollito E; Gned D; DI Dio M; Autorino R; Manfredi M; Fiori C
Minerva Urol Nephrol; 2023 Feb; 75(1):31-41. PubMed ID: 36626117
[TBL] [Abstract][Full Text] [Related]
8. A non-randomized prospective study on the diagnostic performance of perineal prostatic biopsy, directed via diffusion nuclear resonance, in patients with suspected prostate cancer and previous negative transrectal prostate biopsy.
Castellucci R; Linares Quevedo AI; Sánchez Gómez FJ; Cogollos Acuña I; Salmerón Béliz I; Muñoz Fernández de Legaría M; Salinas S; Martínez Piñeiro L
Urologia; 2021 Feb; 88(1):69-76. PubMed ID: 33054607
[TBL] [Abstract][Full Text] [Related]
9. The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies.
Wegelin O; Exterkate L; van der Leest M; Kummer JA; Vreuls W; de Bruin PC; Bosch JLHR; Barentsz JO; Somford DM; van Melick HHE
Eur Urol; 2019 Apr; 75(4):582-590. PubMed ID: 30522912
[TBL] [Abstract][Full Text] [Related]
10. A prospective multi-center randomized comparative trial evaluating outcomes of transrectal ultrasound (TRUS)-guided 12-core systematic biopsy, mpMRI-targeted 12-core biopsy, and artificial intelligence ultrasound of prostate (AIUSP) 6-core targeted biopsy for prostate cancer diagnosis.
Wang X; Xie Y; Zheng X; Liu B; Chen H; Li J; Ma X; Xiang J; Weng G; Zhu W; Wang G; Fang Y; Cheng H; Xie L
World J Urol; 2023 Mar; 41(3):653-662. PubMed ID: 35852595
[TBL] [Abstract][Full Text] [Related]
11. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.
Mannaerts CK; Gayet M; Verbeek JF; Engelbrecht MRW; Savci-Heijink CD; Jager GJ; Gielens MPM; van der Linden H; Beerlage HP; de Reijke TM; Wijkstra H; Roobol MJ
Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233
[TBL] [Abstract][Full Text] [Related]
12. Reliability of prostate imaging reporting and data system version 2.1 for excluding clinically significant prostate cancer using a 1.5 tesla scanner.
Sharqawi A; Drye N; Shugaba A; O'reilly A; Kadry AM; El-Sakka AI
BMC Urol; 2023 Apr; 23(1):69. PubMed ID: 37118694
[TBL] [Abstract][Full Text] [Related]
13. Comparison of PIRADS 3 lesions with histopathological findings after MRI-fusion targeted biopsy of the prostate in a real world-setting.
Schlenker B; Apfelbeck M; Armbruster M; Chaloupka M; Stief CG; Clevert DA
Clin Hemorheol Microcirc; 2019; 71(2):165-170. PubMed ID: 30562897
[TBL] [Abstract][Full Text] [Related]
14. Transperineal Versus Transrectal MRI/TRUS Fusion Targeted Biopsy: Detection Rate of Clinically Significant Prostate Cancer.
Pepe P; Garufi A; Priolo G; Pennisi M
Clin Genitourin Cancer; 2017 Feb; 15(1):e33-e36. PubMed ID: 27530436
[TBL] [Abstract][Full Text] [Related]
15. Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial.
Tonttila PP; Lantto J; Pääkkö E; Piippo U; Kauppila S; Lammentausta E; Ohtonen P; Vaarala MH
Eur Urol; 2016 Mar; 69(3):419-25. PubMed ID: 26033153
[TBL] [Abstract][Full Text] [Related]
16. Detection of clinically significant prostate cancer in biopsy-naïve men: direct comparison of systematic biopsy, multiparametric MRI- and contrast-ultrasound-dispersion imaging-targeted biopsy.
Mannaerts CK; Engelbrecht MRW; Postema AW; van Kollenburg RAA; Hoeks CMA; Savci-Heijink CD; Van Sloun RJG; Wildeboer RR; De Reijke TM; Mischi M; Wijkstra H
BJU Int; 2020 Oct; 126(4):481-493. PubMed ID: 32315112
[TBL] [Abstract][Full Text] [Related]
17. Cancer detection rate of prebiopsy MRI with subsequent systematic and targeted biopsy are superior to non-targeting systematic biopsy without MRI in biopsy naïve patients: a retrospective cohort study.
Washino S; Kobayashi S; Okochi T; Kameda T; Konoshi T; Miyagawa T; Takayama T; Morita T
BMC Urol; 2018 May; 18(1):51. PubMed ID: 29843694
[TBL] [Abstract][Full Text] [Related]
18. Can combined multiparametric magnetic resonance imaging of the prostate and prostate-specific antigen density improve the detection of clinically significant prostate cancer: A prospective single-center cross-sectional study.
Yadav K; Sureka B; Elhence P; Choudhary GR; Pandey H; Garg PK; Yadav T; Khera PS
J Cancer Res Ther; 2021; 17(2):372-378. PubMed ID: 34121679
[TBL] [Abstract][Full Text] [Related]
19. The role of multiparametric magnetic resonance in active surveillance of a low-risk prostate cancer cohort from clinical practice.
Chamorro Castillo L; García Morales L; Ruiz López D; Salguero Segura J; Valero Rosa J; Anglada Curado FJ; Mesa Quesada J; Blanca Pedregosa A; Carrasco Valiente J; Gómez Gómez E
Prostate; 2023 Jun; 83(8):765-772. PubMed ID: 36895160
[TBL] [Abstract][Full Text] [Related]
20. Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men.
Hendriks RJ; van der Leest MMG; Israël B; Hannink G; YantiSetiasti A; Cornel EB; Hulsbergen-van de Kaa CA; Klaver OS; Sedelaar JPM; Van Criekinge W; de Jong H; Mulders PFA; Crawford ED; Veltman J; Schalken JA; Barentsz JO; van Oort IM
Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1110-1119. PubMed ID: 33941866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
